Revenue: As of FY2025 Q1, the actual value is USD 337.71 M, missing the estimate of USD 339.92 M.EPS: As of FY2025 Q1, the actual value is USD 1.16, missing the estimate of USD 1.192.EBIT: As of FY2025 Q1, the actual value is USD 30.51 M.<h3>Personal Care Segment</h3><ul><li>Net Service Revenues: $258,286 thousand for the three months ended March 31, 2025, compared to $208,003 thousand for the same period in 2024, representing a 24.2% increase.</li><li>Cost of Services Revenues: $186,964 thousand for the three months ended March 31, 2025, compared to $152,536 thousand for the same period in 2024, representing a 22.6% increase.</li><li>Gross Profit: $71,322 thousand for the three months ended March 31, 2025, compared to $55,467 thousand for the same period in 2024, representing a 28.6% increase.</li><li>Segment Operating Income: $47,592 thousand for the three months ended March 31, 2025, compared to $40,022 thousand for the same period in 2024, representing an 18.9% increase.</li></ul><h3>Hospice Segment</h3><ul><li>Net Service Revenues: $61,437 thousand for the three months ended March 31, 2025, compared to $55,863 thousand for the same period in 2024, representing a 10.0% increase.</li><li>Cost of Services Revenues: $32,269 thousand for the three months ended March 31, 2025, compared to $28,967 thousand for the same period in 2024, representing an 11.4% increase.</li><li>Gross Profit: $29,168 thousand for the three months ended March 31, 2025, compared to $26,896 thousand for the same period in 2024, representing an 8.4% increase.</li><li>Segment Operating Income: $14,617 thousand for the three months ended March 31, 2025, compared to $13,457 thousand for the same period in 2024, representing an 8.6% increase.</li></ul><h3>Home Health Segment</h3><ul><li>Net Service Revenues: $17,985 thousand for the three months ended March 31, 2025, compared to $16,880 thousand for the same period in 2024, representing a 6.5% increase.</li><li>Cost of Services Revenues: $10,798 thousand for the three months ended March 31, 2025, compared to $11,066 thousand for the same period in 2024, representing a 2.4% decrease.</li><li>Gross Profit: $7,187 thousand for the three months ended March 31, 2025, compared to $5,814 thousand for the same period in 2024, representing a 23.6% increase.</li><li>Segment Operating Income: $3,014 thousand for the three months ended March 31, 2025, compared to $1,277 thousand for the same period in 2024, representing a 136.0% increase.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $18,949 thousand for the three months ended March 31, 2025, compared to $38,678 thousand for the same period in 2024.</li><li>Net Cash Used in Investing Activities: - $1,378 thousand for the three months ended March 31, 2025, compared to - $1,750 thousand for the same period in 2024.</li><li>Net Cash Used in Financing Activities: - $19,528 thousand for the three months ended March 31, 2025, compared to - $25,000 thousand for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue expanding its presence in current markets and entering new markets through acquisitions, aiming to have all three levels of in-home care in its markets.</li><li>Non-Core Business: The company has divested its New York operations, which did not fit its growth strategy, and recorded deferred payments of $3.8 million during the three months ended March 31, 2025.</li></ul>

Addus Homecare | 10-Q: FY2025 Q1 Revenue Misses Estimate at USD 337.71 M